Tips on minimizing, recording, and handling surgical complicationsJanuary 10, 2024As the saying goes, “Hope for the best but prepare for the worst.” Dealing with complications starts with preparing for them.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
A pharmaceutical approach to pain managementJanuary 9, 2024Recognizing, assessing, and treating pain is not only essential for the comfort and well-being of our patients, but also contributes to their overall recovery and quality of life.
$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
Fixing a case of mandibular osteomyelitisJanuary 4, 2024This month's 'Dental Pearls' column covers a case where a concerning swelling of the mandible turns out to have a good prognosis, but due to a different etiology.
Navigating caregiver burdensJanuary 3, 2024Addressing and reducing the numerous burdens associated with long-term care plan can help improve the quality of life of the owner, the pet, and the veterinarian involved.
North Carolina will soon mandate veterinarians to declare gabapentin useDecember 20, 2023As part of Gov. Roy Cooper’s North Carolina Opioid and Substance Use Action Plan, he signed into law this past June a new requirement to report the use of the pain management medication
Holiday hazards: 'Tis the season for sharing life-saving tipsDecember 19, 2023Delicious holiday foods are just one of the seasonal pitfalls facing clients and their pets. Help them stay accident-free with hazard management and avoidance tips from emergency, critical care, and toxicology experts and practitioners.
Gallant Therapeutics announces study for feline stem cell therapyDecember 18, 2023Gallant Therapeutics, an animal health biotechnology company announced the launch of a study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis (FCGS), the JEDI study.
Pet Business names the top pet products of 2023December 15, 2023With limited space in most veterinary practice’s retail centers, reviewing this year winners is one possible route in determining what to sell or gift clients for referrals.
South Korea eyes an US$11.5 billion pet industry by 2027December 14, 2023South Korea has set a goal to turn its entire pet market into a 15 trillion won industry (approximately US$11.47 billion at present) by 2027 with government-led initiatives to further prepare for its growth, reports Petfood Industry’s website.
